Glybera gene therapy in approval process in Europe

Europe is on the process of approving a gene therapy for the first time, in what would be a landmark moment for the field. Gene therapies alter a patient’s DNA to treat inherited diseases passed from parent to child. The European Medicines Agency has recommended a therapy for a rare genetic disease which leaves people [...]



































